BIOPORTO DIAGNOSTICS A/S

CVRCVR number18645882

Core data

Name	BIOPORTO DIAGNOSTICS A/S
Address	Tuborg Havnevej 15 st, 2900, Hellerup
Founded	Jul 1, 1995
	29 / 26
Locations (P-units)	1 View locations
Website	https://bioporto.com/
LinkedIn	bioporto-diagnostics-a-s
Branch	Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Name	BIOPORTO DIAGNOSTICS A/S
Address	Tuborg Havnevej 15 st, 2900, Hellerup
Founded	Jul 1, 1995
	29 / 26

Locations (P-units)	1 View locations
Website	https://bioporto.com/
LinkedIn	bioporto-diagnostics-a-s
Branch	Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of BIOPORTO DIAGNOSTICS A/S

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.

Free account

Description

BioPorto is an in vitro diagnostics company developing actionable biomarker products, including NGAL-based tests and research tools, to help clinicians assess and manage clinical conditions, particularly acute kidney injury.

BioPorto provides tests, antibodies, and biomarker-based tools for clinicians and researchers. Its flagship NGAL products support the risk assessment, diagnosis, and management of acute kidney injury, while its ELISA kits support preclinical animal research and Phase 1 human clinical trials.

Products & services

The NGAL Test™ · ProNephro AKI (NGAL) · Human NGAL ELISA kits · Animal NGAL ELISA kits · Tests and antibodies

Industries

In vitro diagnostics · Biomarker development · Healthcare diagnostics · Research tools

Customer types

Clinicians · Researchers · Healthcare providers

Financials

View detailed financials

Company financials

Reporting period	2025DKK	2024Locked	2023Locked	2022Locked	2021Locked	2020Locked	2019Locked	2018Locked	2017Locked
Revenue	40,286,970	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Gross profit	-18,865,571	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Operating profit	-68,946,391	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Profit before tax	-86,898,096	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Net income	-81,398,096	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Total assets	24,806,739	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Equity	-837,580,713	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Avg. employees	26	Locked	Locked	Locked	Locked	Locked	Locked	Locked	Locked
2017–2025 Unlock financial history

Datapublica Risk Score

Locked

Assesses the risk of financial distress using the company’s accounts, history, and connections.

Company score

0 · Low100 · High

What goes into the assessment

Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details

Standard: Score and risk bandPro: Also a detailed explanation of the factors

See plans Learn about Risk Score

Contact

From cvr.dk

Contact	Phone	Email
Company	4529****Show full	in**@bioporto.comShow full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Person	Roles	Titles
Carsten Buhl	Roles BoardManagement	TitlesBESTYRELSESMEDLEM • ADM. DIR.
Gry Louise Husby Larsen	Roles Board	TitlesFORMAND
Klaus Juhl Wulff	Roles Board	TitlesBESTYRELSESMEDLEM

Auditor

Audit firm	Auditor	Role	From
Deloitte Statsautoriseret Revisionspartnerselskab	AuditorLars Hansen	RoleState Authorised Public Accountant	FromApr 9, 2026
Deloitte Statsautoriseret Revisionspartnerselskab	Auditor—	Role—	FromApr 9, 2026

Legal owners

View ownership diagram

Owner	Ownership	Voting rights	From
BIOPORTO A/S	Ownership100 %	Voting rights100 %	FromJan 9, 2004

Ultimate owners